These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9466358)

  • 1. Technetium-99m direct radiolabeling of monoclonal antibody ior egf/r3.
    Morales AA; Crespo FZ; Gandolff GN; Iznaga Escobar N; Pérez NP; Hernández JC
    Nucl Med Biol; 1998 Jan; 25(1):25-30. PubMed ID: 9466358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies.
    Mishra AK; Iznaga-Escobar N; Figueredo R; Jain VK; Dwarakanath BS; Pérez-Rodríguez R; Sharma RK; Mathew TL
    Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):653-60. PubMed ID: 12616957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma.
    Morales-Morales A; Ducongé J; Caballero-Torres I; Núñez-Gandolff G; Fernández E; Iznaga-Escobar N
    Nucl Med Biol; 1999 Apr; 26(3):275-9. PubMed ID: 10363798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy.
    Pnwar P; Iznaga-Escobar N; Mishra P; Srivastava V; Sharma RK; Chandra R; Mishra AK
    Cancer Biol Ther; 2005 Aug; 4(8):854-60. PubMed ID: 16082184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct and indirect labeling with 99mTc of an antireceptor monoclonal antibody of EGF].
    Calderón Sánchez O; Zayas Crespo F; Leyva Montaña R; Beckford Vera D; Gómez JA
    Rev Esp Med Nucl; 2005; 24(1):38-44. PubMed ID: 15701345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability.
    Morales AA; Núñez-Gandolff G; Pérez NP; Véliz BC; Caballero-Torres I; Ducongé J; Fernández E; Crespo FZ; Veloso A; Iznaga-Escobar N
    Nucl Med Biol; 1999 Aug; 26(6):717-23. PubMed ID: 10587113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, biodistribution and dosimetry of 99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats.
    Iznaga Escobar N; Morales AM; Ducongé J; Torres IC; Fernández E; Gómez JA
    Nucl Med Biol; 1998 Jan; 25(1):17-23. PubMed ID: 9466357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
    Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
    Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies.
    Morales AA; Ducongé J; Alvarez-Ruiz D; Becquer-Viart ML; Núñez-Gandolff G; Fernández E; Caballero-Torres I; Iznaga-Escobar N
    Nucl Med Biol; 2000 Feb; 27(2):199-206. PubMed ID: 10773550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
    Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
    Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 188Re-labeled anti-epidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stability.
    Iznaga-Escobar N; Ramirez IL; Izquierdo JC; Suárez L; Morales D; Pérez-Rodríguez R
    Methods Find Exp Clin Pharmacol; 2003 Nov; 25(9):703-11. PubMed ID: 14685297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiolabeling of a new agent for the study of colorectal tumors].
    Quesada Cepero W; Pimentel González G; Oliva González J; Pérez Tenorio G; Aguiar Cabeza E; Sánchez Monzón I; Hernández Romero O; Rebustillo Sierra M
    Rev Esp Med Nucl; 1998; 17(2):82-8. PubMed ID: 9611277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies.
    Iznaga Escobar N; Morales A; Núñez G
    Nucl Med Biol; 1996 Jul; 23(5):641-4. PubMed ID: 8905830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.
    Gooden CS; Snook DE; Epenetos AA
    Cell Biophys; 1993; 22(1-3):49-59. PubMed ID: 7889542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
    Garron JY; Moinereau M; Pasqualini R; Saccavini JC
    Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
    Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
    J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
    Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
    J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
    Zalutsky MR; Xu FJ; Yu Y; Foulon CF; Zhao XG; Slade SK; Affleck DJ; Bast RC
    Nucl Med Biol; 1999 Oct; 26(7):781-90. PubMed ID: 10628557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI).
    Orlova A; Bruskin A; Sivaev I; Sjöberg S; Lundqvist H; Tolmachev V
    Anticancer Res; 2006; 26(2A):1217-23. PubMed ID: 16619527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting using anti-epidermal growth factor receptor (ior egf/r3) immunoconjugate with a tetraaza macrocyclic agent (DO3A-EA).
    Mishra G; Panwar P; Mishra AK
    Mol Imaging; 2012; 11(5):408-16. PubMed ID: 22954185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.